The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis
Chimowitz, M. I., Lynn, M. J., Derdeyn, C. P., Turan, T. N., Fiorella, D., Lane, B. F., Janis, L. S., Lutsep, H. L., Barnwell, S. L., Waters, M. F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105335 · Cited by 1,901
Weinstein, M. C., O'Brien, B., Hornberger, J., Jackson, J., Johannesson, M., McCabe, C., & Luce, B. R. (2003) · Value in Health · doi:10.1046/j.1524-4733.2003.00234.x · Cited by 1,172
Ramsey, S., Willke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., Cook, J., Glick, H., Liljas, B., Petitti, D., et al. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.00045.x · Cited by 720
Self-citationBerger, M. L., Mamdani, M., Atkins, D., & Johnson, M. L. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00600.x · Cited by 409
Carlson, J. J., Sullivan, S. D., Garrison, L. P., Neumann, P. J., & Veenstra, D. L. (2010) · Health Policy · doi:10.1016/j.healthpol.2010.02.005 · Cited by 286
Self-citationJohnson, M. L., Crown, W., Martin, B. C., Dormuth, C. R., & Siebert, U. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00602.x · Cited by 285 · cited 1×
“[47] Johnson ML, Crown W, Martin BC, et al.”
BackgroundClaxton, K. P., & Sculpher, M. J. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624110-00003 · Cited by 279
Adamski, J., Godman, B., Ofierska-Sujkowska, G., Osińska, B., Herholz, H., Wendykowska, K., Laius, O., Jan, S., Sermet, C., Zara, C., et al. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-153 · Cited by 255
Garrison, L. P., Mansley, E. C., Abbott, T. A., Bresnahan, B. W., Hay, J. W., & Smeeding, J. (2010) · Value in Health · doi:10.1111/j.1524-4733.2009.00660.x · Cited by 203
Self-citationBerger, M. L., Dreyer, N., Anderson, F., Towse, A., Sedrakyan, A., & Normand, S.-L. (2012) · Value in Health · doi:10.1016/j.jval.2011.12.010 · Cited by 189
Self-citationWhat principles should govern the use of managed entry agreements?
Klemp, M., Frønsdal, K. B., & Facey, K. M. (2011) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462310001297 · Cited by 165
Czoski-Murray, C., Lloyd Jones, M., McCabe, C., Claxton, K., Oluboyede, Y., Roberts, J., Nicholl, J., Rees, A., Reilly, C., Young, D., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16500 · Cited by 161
Walker, S., Sculpher, M., Claxton, K., & Palmer, S. (2012) · Value in Health · doi:10.1016/j.jval.2011.12.013 · Cited by 148
Coverage with Evidence Development: An examination of conceptual and policy issues
Hutton, J., Trueman, P., & Henshall, C. (2007) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462307070651 · Cited by 146
Stafinski, T., McCabe, C. J., & Menon, D. (2010) · PharmacoEconomics · doi:10.2165/11530820-000000000-00000 · Cited by 136
Claxton, K., Palmer, S., Longworth, L., Bojke, L., Griffin, S. C., McKenna, C., Soares, M. O., Spackman, E., & Youn, J.-H. (2012) · Health Technology Assessment · doi:10.3310/hta16460 · Cited by 134
Towse, A., & Garrison, L. P. (2010) · PharmacoEconomics · doi:10.2165/11314080-000000000-00000 · Cited by 125
Self-citationDangerous omissions: the consequences of ignoring decision uncertainty
Griffin, S. C., Claxton, K., Palmer, S., & Sculpher, M. (2010) · Health Economics · doi:10.1002/hec.1586 · Cited by 119
Neumann, P. J., Chambers, J. D., Simon, F. L., & Meckley, L. M. (2011) · Health Affairs · doi:10.1377/hlthaff.2010.1147 · Cited by 107
Boggild, M., Palace, J. A., Barton, P. M., Ben‐Shlomo, Y., Bregenzer, T., Dobson, C., & Gray, R. G. (2009) · BMJ · doi:10.1136/bmj.b4677 · Cited by 104
Rapple, B. A. (1994) · Education Policy Analysis Archives · doi:10.14507/epaa.v2n1.1994 · Cited by 103
Pickin, M., Cooper, C. L., Chater, T., O’Hagan, A., Abrams, K. R., Cooper, N. J., Boggild, M., Palace, J. A., Ebers, G. C., Chilcott, J. B., et al. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-1 · Cited by 95
Coverage with Evidence Development: Applications and issues
Trueman, P., Grainger, D. L., & Downs, K. E. (2010) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462309990882 · Cited by 93
Access with Evidence Development Schemes: A Framework for Description and Evaluation
McCabe, C. J., Stafinski, T., Edlin, R. P., & Menon, D. (2010) · PharmacoEconomics · doi:10.2165/11530850-000000000-00000 · Cited by 88
Multiple sclerosis risk sharing scheme: a costly failure
Raftery, J. (2010) · BMJ · doi:10.1136/bmj.c1672 · Cited by 86
The National Oncologic PET Registry (NOPR): Design and Analysis Plan
Hillner, B. E., Liu, D., Coleman, R. E., Shields, A. F., Gareen, I. F., Hanna, L., Stine, S. H., & Siegel, B. A. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043687 · Cited by 82
Registries That Show Efficacy: Good, but Not Good Enough
Levine, M. N., & Julian, J. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.3996 · Cited by 80
False Hope: Bone Marrow Transplantation for Breast Cancer
Rettig, R. A., Jacobson, P., Farquhar, C. M., et al. (2007) · Cited by 77
The Option Value of Delay in Health Technology Assessment
Eckermann, S. D., & Willan, A. R. (2008) · Medical Decision Making · doi:10.1177/0272989x07312477 · Cited by 75
Access with Evidence Development: The US Experience
Mohr, P. E., & Tunis, S. (2010) · PharmacoEconomics · doi:10.2165/11531050-000000000-00000 · Cited by 61
Self-citationHollingworth, W., Turner, J. A., Welton, N. J., Comstock, B. A., & Deyo, R. A. (2011) · Spine · doi:10.1097/brs.0b013e31822a867c · Cited by 58
Towse, A. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03740.x · Cited by 56
Self-citationGlobally optimal trial design for local decision making
Eckermann, S. D., & Willan, A. R. (2008) · Health Economics · doi:10.1002/hec.1353 · Cited by 55
Chalkidou, K., Hoy, A. R., & Littlejohns, P. (2007) · Journal of the Royal Society of Medicine · doi:10.1177/014107680710001013 · Cited by 52
Antoñanzas, F., Juárez-Castelló, C. A., & Rodríguez‐Ibeas, R. (2011) · Health Economics Policy and Law · doi:10.1017/s1744133111000016 · Cited by 49
Paying for Outcomes: Innovative Coverage and Reimbursement Schemes for Pharmaceuticals
Carlson, J. J., Garrison, L. P., & Sullivan, S. D. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.8.683 · Cited by 49
Self-citationCoverage with evidence development: The Ontario experience
Levin, L., Goeree, R. A., Levine, M. N., Krahn, M. D., Easty, T., Brown, A., & Henry, D. A. (2011) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462311000018 · Cited by 48
Patient access schemes for high-cost cancer medicines
Williamson, S. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70402-4 · Cited by 42
Evidence, Economics, And Emphysema: Medicare’s Long Journey With Lung Volume Reduction Surgery
Ramsey, S. D., & Sullivan, S. D. (2005) · Health Affairs · doi:10.1377/hlthaff.24.1.55 · Cited by 40
Coverage with Evidence Development for Pharmaceuticals: A Policy in Evolution?
Lexchin, J. (2011) · International Journal of Health Services · doi:10.2190/hs.41.2.h · Cited by 14
Comparative Effectiveness Research and Policy
Turner, J. A., Hollingworth, W., Comstock, B. A., & Deyo, R. A. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181d9e622 · Cited by 12
Outcomes-based Risk-sharing Schemes: Is There a Potential Role in the Asia-Pacific Markets?
Coulton, L., Annemans, L., Carter, R., Herrera, M. B., Thabrany, H., Lim, J., Lee, K. K. C., Chen, W., Chaiyakunapruk, N., Chern, H., et al. (2012) · Health Outcomes Research in Medicine · doi:10.1016/j.ehrm.2012.07.002 · Cited by 11
Gliklich, R. E., Leavy, M. B., Velentgas, P., Dreyer, N. A., Tunis, S., Mohr, P. E., Messner, D. A., Moloney, R., Karkare, S. U., Dubois, R. W., et al. (2012) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.12.25 · Cited by 10
Self-citation
Cited by
Berger, M. L., Sox, H., Willke, R. J., Brixner, D. L., Eichler, H., Goettsch, W., Madigan, D., Makady, A., Schneeweiss, S., Tarricone, R., et al. (2017) · Value in Health · doi:10.1016/j.jval.2017.08.3019 · Cited by 456
Berger, M. L., Sox, H., Willke, R. J., Brixner, D. L., Eichler, H., Goettsch, W., Madigan, D., Makady, A., Schneeweiss, S., Tarricone, R., et al. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4297 · Cited by 344
Addressing Dementia: The OECD Response
OECD (2015) · OECD Health Policy Studies · doi:10.1787/9789264231726-en · Cited by 327
Performance-based contracting: a literature review and future research directions
Selviaridis, K., & Wynstra, F. (2015) · International Journal of Production Research · doi:10.1080/00207543.2014.978031 · Cited by 255
Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy
Drummond, M. F., Neumann, P. J., Sullivan, S. D., Fricke, F.-U., Tunis, S., Dabbous, O., & Toumi, M. (2019) · Value in Health · doi:10.1016/j.jval.2019.03.012 · Cited by 92
Metadata
- Authors
- Garrison, L. P., Towse, A., Briggs, A., de Pouvourville, G., Grueger, J., Mohr, P. E., Severens, J. L. (., Siviero, P., & Sleeper, M.
- Venue
- Value in Health
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 16
- Issue
- 5
- Pages
- 703-719
- ISSN
- 1098-3015 (ISSN-L)
- OpenAlex
- W2163878956
- Cited by
- 314
- References
- 43
- FWCI
- 41.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.